Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2026-01-08

Clinical Trial Update: Study Evaluating Patients With Cystinuria and Efficacy and Safety Exploratory Study in the Youngest Children [Phase 2, Phase 3]

View source ↗

Summary

A cystinuria trial (Phase 2/Phase 3) sponsored by Advicenne Pharma has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Advicenne Pharma | Conditions: Cystinuria | Phase 2, Phase 3 | Status: WITHDRAWN